Myeloma UK Rapid Review of Non-Specific Symptom Pathways

Explore our guidance designed to aid NHS England and NHS Cancer Alliances in delivering earlier myeloma diagnosis.

This report outlines practical recommendations aimed at supporting NHS England and NHS Cancer Alliances improve the prompt detection of myeloma, which is essential for better patient outcomes and easing the strain on healthcare services.

The Non-Specific Symptom (NSS) Pathways, launched by NHS England, offer a unique opportunity to meet the urgent need for faster myeloma diagnosis. Detecting myeloma early is key to preventing disease progression and beginning targeted treatments. NSS pathways provide a way to diagnose myeloma, especially in cases where it may not initially be suspected by healthcare professionals.